CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Cholesterol-Lowering Agents Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension Door-to-balloon time and mortality among patients undergoing primary PCI Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention Age-specific gender differences in early mortality following ST-segment elevation myocardial infarction in China 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA /ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Review Article2019 Feb;124(3):364-385.

JOURNAL:Circ Res. Article Link

Cholesterol-Lowering Agents

Rosenson RS, Hegele RA, Koenig W. Keywords: cardiovascular disease; cholesterol; myocardial infarction; patients; subtilisin

FULL TEXT PDF